Democratic Republic of the Congo vs Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Democratic Republic of the Congo
1.4%
in 2024
Togo
1.4%
in 2024
Democratic Republic of the Congo rank
22nd
Togo rank
22nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Democratic Republic of the Congo
- Togo
How they compare
Democratic Republic of the Congo currently reports 1.4% against 1.4% in Togo, a difference of 0.0%.
Across all 10 years both countries report, Togo has been ahead every year.
Democratic Republic of the Congo ranks 22nd and Togo ranks 22nd of 246 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of the Congo | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.9% | 0.4% | Togo |
| 2020s | 1.4% | 1.5% | 0.1% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Democratic Republic of the Congo or Togo?
- Democratic Republic of the Congo, at 1.4% against 1.4% in Togo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Democratic Republic of the Congo and Togo?
- 0.0%, with Democratic Republic of the Congo ahead.
- How many years of comparable data are there for Democratic Republic of the Congo and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do Democratic Republic of the Congo and Togo rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Democratic Republic of the Congo ranks 22nd and Togo ranks 22nd of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.